Does MOLSIDOMINE Cause Hyperthyroidism? 36 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 36 reports of Hyperthyroidism have been filed in association with MOLSIDOMINE. This represents 9.4% of all adverse event reports for MOLSIDOMINE.
36
Reports of Hyperthyroidism with MOLSIDOMINE
9.4%
of all MOLSIDOMINE reports
36
Deaths
36
Hospitalizations
How Dangerous Is Hyperthyroidism From MOLSIDOMINE?
Of the 36 reports, 36 (100.0%) resulted in death, 36 (100.0%) required hospitalization, and 31 (86.1%) were considered life-threatening.
Is Hyperthyroidism Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MOLSIDOMINE. However, 36 reports have been filed with the FAERS database.
What Other Side Effects Does MOLSIDOMINE Cause?
Toxic epidermal necrolysis (84)
Blister (54)
Erythema (53)
Nausea (48)
Multiple organ dysfunction syndrome (45)
Respiratory disorder (44)
Diarrhoea (41)
Hypertension (37)
Cholecystitis (36)
Electrolyte imbalance (36)
What Other Drugs Cause Hyperthyroidism?
LEVOTHYROXINE (1,681)
AMIODARONE (1,410)
NIVOLUMAB (934)
PEMBROLIZUMAB (780)
IPILIMUMAB (525)
CARBOPLATIN (432)
ATEZOLIZUMAB (416)
PACLITAXEL (261)
ALEMTUZUMAB (236)
LENVATINIB (231)
Which MOLSIDOMINE Alternatives Have Lower Hyperthyroidism Risk?
MOLSIDOMINE vs MOMELOTINIB
MOLSIDOMINE vs MOMETASONE
MOLSIDOMINE vs MOMETASONE FUROATE
MOLSIDOMINE vs MOMETASONE FUROATE\OLOPATADINE
MOLSIDOMINE vs MONOMETHYL